Henry Schein, Inc. (HSIC) Shares Bought by Janus Henderson Group PLC
Janus Henderson Group PLC increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 394.1% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 1,465,303 shares of the company’s stock after purchasing an additional 1,168,763 shares during the period. Janus Henderson Group PLC owned approximately 1.85% of Henry Schein worth $268,173,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of HSIC. YorkBridge Wealth Partners LLC lifted its position in shares of Henry Schein by 5.2% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after purchasing an additional 28 shares during the last quarter. Sun Life Financial INC lifted its position in shares of Henry Schein by 8,185.7% during the 2nd quarter. Sun Life Financial INC now owns 580 shares of the company’s stock worth $106,000 after purchasing an additional 573 shares during the last quarter. Lee Financial Co acquired a new position in shares of Henry Schein during the 2nd quarter worth about $161,000. Westside Investment Management Inc. acquired a new position in shares of Henry Schein during the 1st quarter worth about $168,000. Finally, Acrospire Investment Management LLC lifted its position in shares of Henry Schein by 150.0% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock worth $183,000 after purchasing an additional 600 shares during the last quarter. 44.52% of the stock is owned by institutional investors and hedge funds.
In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the sale, the senior vice president now owns 17,841 shares of the company’s stock, valued at $3,077,750.91. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.27% of the company’s stock.
HSIC has been the subject of several research analyst reports. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price target on the stock in a research note on Monday, August 7th. UBS AG restated a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. Piper Jaffray Companies upgraded Henry Schein from a “neutral” rating to an “overweight” rating in a research note on Friday, September 15th. Finally, BidaskClub lowered Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and seven have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $92.17.
ILLEGAL ACTIVITY WARNING: “Henry Schein, Inc. (HSIC) Shares Bought by Janus Henderson Group PLC” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/10/06/henry-schein-inc-hsic-shares-bought-by-janus-henderson-group-plc.html.
Henry Schein, Inc. (HSIC) traded up 0.05% during midday trading on Friday, reaching $81.62. The company had a trading volume of 131,391 shares. Henry Schein, Inc. has a one year low of $73.11 and a one year high of $93.50. The stock’s 50 day moving average is $83.62 and its 200 day moving average is $87.57. The company has a market capitalization of $12.91 billion, a PE ratio of 23.85 and a beta of 1.08.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 8th. The company reported $0.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.86 by $0.02. The business had revenue of $3.06 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the firm posted $0.82 earnings per share. Equities research analysts forecast that Henry Schein, Inc. will post $3.64 earnings per share for the current fiscal year.
Henry Schein announced that its Board of Directors has authorized a stock repurchase program on Monday, September 18th that allows the company to repurchase $400.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 6.3% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its stock is undervalued.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.